Ropivacaine- the latest local anaesthetic in the indian market

Journal of Anaesthesiology Clinical Pharmacology

Volumn 26, Issue 2, 2010, Pages 223-228

  Agarwal, Ankit ^a   Verma, R K ^a   Srivastava, Shivika ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BUPIVACAINE; FLUVOXAMINE; IMIPRAMINE; MEPIVACAINE; NEUROMUSCULAR BLOCKING AGENT; ROPIVACAINE; THEOPHYLLINE;

AIRWAY; ANALGESIA; ANESTHESIOLOGICAL TECHNIQUES; APGAR SCORE; ARTICLE; ASSISTED VENTILATION; BRACHIAL PLEXUS ANESTHESIA; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CESAREAN SECTION; CHONDROLYSIS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONVULSION; DELIVERY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CONTRAINDICATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG MARKETING; DRUG METABOLISM; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG WITHDRAWAL; FETUS BRADYCARDIA; FETUS DISEASE; FETUS DISTRESS; FETUS TACHYCARDIA; GERIATRICS; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INDIA; INTRAVASCULAR DRUG ADMINISTRATION; LABOR; LOCAL ANESTHESIA; MOTOR NERVE BLOCK; NEONATAL FEVER; NEONATAL RESPIRATORY DISORDER; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEONATAL TACHYPNEA; NERVE BLOCK; NEWBORN DISEASE; NEWBORN HYPOGLYCEMIA; NEWBORN INFECTION; NEWBORN JAUNDICE; NONHUMAN; OBSTETRICS; PAIN; PAIN ASSESSMENT; PERIPHERAL NERVE; PERIPHERAL NERVE BLOCK; PHYSICAL CHEMISTRY; POSTOPERATIVE PAIN; PREGNANCY; RECOMMENDED DRUG DOSE; REGIONAL ANESTHESIA; RESPIRATION DEPRESSION; SIDE EFFECT; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; TREATMENT INDICATION;

EID: 77954359802     PISSN: 09709185     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Owen MD, Dean LS. Ropivacaine. Expert Opin Pharmacother 2000; 1(2): 325-336
2. Reutsch YA, Boni T, Borgeat A. From cocaine to ropivacaine: the history of local anaesthetic drugs. Current Topics in Medicinal Chemistry 2001: 1: 175-182
3. Liu BG, Zhuang XL, Li ST, Xu GH. The effects of ropivacaine on sodium currents in dorsal horn neurons of neonatal rats. Anesth Analg 2000; 90(5): 1034-1048
4. Simpson D, et al. Ropivacaine-A review of its use in regional anesthesia and acute pain management. Drugs 2005; 65(18): 2675-2717
5. Tuttle AA, Katz JA, Bridenbaugh PO, Quinlan R, Knarr D. A double blind comparison of the abdominal wall relaxation produced by epidural 0.75% ropivacaine and 0.75% bupivacaine in gynecologic surgery. Reg Anesth 1995; 20(6): 515-520
6. Bacchman-Mennenga B, Veit G, Steinicke B, Biscoping J, Heesen M. Efficacy of sufentanil addition to ropivacaine epidural anesthesia for cesarean section. Acta Anaesthesiol Scand 2005; 49(4): 532-547
7. Evron S, Glezerman M, Sadan O, Boaz M, Ezri T. Patient controlled epidural analgesia for labor pain: effect on labor, delivery and neonatal outcome of 0.125% bupivacaine vs 0.2% ropivacaine. Int J Obstet Anaesth 2004 Jan;13(1):5-10
8. Halpern SH, Carvalho B. Patient controlled epidural analgesia for labor. Anesth Analg. 2009; 108(3): 921-938
9. Katz JA, Knarr D, Bridenbaugh PO. A double blind comparison of 0.5% bupivacaine and 0.75% ropivacaine administered epidurally in humans. Reg Anesth.1990; 15(5): 250-262
10. Sinardi D, Marino A, Chillemi S, Sillotti R, Mondello E. Sciatic nerve block with lateral popliteal approach for hallux valgus correction. Comparison between 0.5% bupivacaine and 0.75% ropivacaine. Minerva Anestesiol. 2004; 70(9): 625-639
11. Keramidas EG, Rodopoulou SG. Ropivacaine versus lignocaine in digital nerve blocks: a prospective study. Plast Reconstr Surg 2007; 119(7): 2148-2152
12. Jokinen MJ, Neuvonen PJ, Lindgren L, Hockerstedt K, Sjovall J, Breuer O, et al. Pharmacokinetics of ropivacaine in patients with chronic end stage liver disease. Anesthesiology. 2007;106(1): 43-55
13. Jokinen M. The pharmacokinetics of ropivacaine in hepatic and renal insufficiency. Best Practice & Research Clinical Anesthesiology. 2005; 19:269-274
14. Guinet P, Estebe JP, Ratajczak-Enselme M, Bansard JY, Chevanne F, Bec D, et al. Electrocardiographic and hemodynamic effects of intravenous infusion of bupivacaine, ropivacaine, levobupivacaine, and lignocaine in anesthetiszed ewes. Reg Anaesth Pain Med 2009; 34(1): 17-23
15. Dernedde M, Furlan D, Verbesselt R, Gepts E, Boogaerts JG. Grand mal convulsion after an accidental intravenous injection of ropivacaine. Anesth Analg 2004; 98(2): 521-533
16. Arlannder E, Ekstrom G, Alm C, et al. Metabolism of ropivacaine in humans is mediated by, CYP1A2 and to a minor extent by CYP3A4: an interaction study with fluvoxamine and ketoconazole as in vivo inhibitors. Clin Pharmacol Ther 1998; 64: 484-491
17. Santos AC, Pederson H, Sallusto JA, Johnson HV, Morishima HO, Finster M, et al. Pharmacokinetics of ropivacaine in nonpregnant and pregnant ewes. Anesth Analg 1990; 70(3): 262-276
18. Santos AC, Arthur GR, Pederson H, Morishima HO, Finster M, Covino BG. Systemic toxicity of ropivacaine during ovine pregnancy. Anesthesiology 1991 Jul;75(1):137-141
19. Morrison SG, Dominguez JJ, Frascarolo P, Reiz S. A comparison of the electrocardiographic cardiotoxic effects of racemic bupivacaine, levobupivacaine, and ropivacaine in anesthetized swine. Anesth Analg 2000 Jun;90(6):1308-1314
20. Steinstra R. The place of ropivacaine in anesthesia. Acta Anaesthesiol Belg 2003;54(2):141-158